Piper Jaffray Downgrades Imprivata (IMPR) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. FMC
10. MRSH

Go back to Piper Jaffray Downgrades Imprivata (IMPR) to Neutral

Leerink Partners Downgrades Imprivata (IMPR) to Market Perform; Doesn't See Cerner (CERN) Making Competing Bid

July 13, 2016 5:33 PM EDT

Leerink Partners downgraded Imprivata (NYSE: IMPR) from Outperform to Market Perform after the company agreed to be acquired by Thoma Bravo for $19.25/share.

Analyst David Larsen commented, "While Cerner (NASDAQ: CERN) (OP) could... More

Stifel Downgrades Imprivata (IMPR) to Hold

July 13, 2016 1:58 PM EDT

Stifel downgraded Imprivata (NYSE: IMPR) from Buy to Hold and removed its price target (prior $20.00).

For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.

Shares of Imprivata closed at $14.50 yesterday.

... More

Thoma Bravo to Acquire Imprivata (IMPR) for $544M

July 13, 2016 8:01 AM EDT

Imprivata (NYSE: IMPR) entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, LLC, a leading private equity investment firm. Under the terms of the agreement, shareholders of record will receive $19.25 in cash per share of Imprivata common stock, which represents a 33% premium to Imprivatas last closing stock price of $14.50. The value of the transaction is approximately $544 million.

Were tremendously excited about Thoma Bravos investment in our company and believe this... More